Product
Brimonidine tartrate ophthalmic solution
1 clinical trial
4 indications
Indication
GlaucomaIndication
Open-AngleIndication
PtosisIndication
Primary Open-Angle GlaucomaClinical trial
The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%Status: Not yet recruiting, Estimated PCD: 2030-06-01